TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012
TCL Archive In Brief: Adamson is Acting Frederick Director; Fischinger Heads Hollings Center; ASCO Has New Exec. Dir. February 12, 1993